Cambridge Cognition Share Forecast, Price & News

GBX 141.50
+1.50 (+1.07 %)
(As of 04/16/2021 12:00 AM ET)
Today's Range
Now: GBX 141.50
50-Day Range
MA: GBX 87.28
52-Week Range
Now: GBX 141.50
Volume243,857 shs
Average Volume84,887 shs
Market Capitalization£44.11 million
P/E RatioN/A
Dividend YieldN/A
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health solutions in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IÂ-IV or a cognitive testing software that enhances the chances of success and minimizing the risk of failure in neuroscience research; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; and CANTAB Insight, a medical device that helps to determine an individual's cognitive health. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.
Cambridge Cognition logo

Industry, Sector and Symbol

Industry Diagnostics & Research
Phone44 1223 810 700
Year FoundedN/A



Sales & Book Value

Annual Sales£6.74 million
Cash FlowGBX 10.83 per share
Book ValueGBX 0.20 per share



Market Cap£44.11 million
Next Earnings DateN/A


Cambridge Cognition (LON:COG) Sets New 1-Year High at $93.00
March 30, 2021 |  americanbankingnews.com
How to support your dyslexic child
March 5, 2021 |  msn.com
Cambridge Cognition Holdings PLC
November 27, 2020 |  bloomberg.com
Diurnal Grp Share News (DNL)
November 15, 2020 |  lse.co.uk
See More Headlines


Overall MarketRank

0.28 out of 5 stars

Analyst Opinion: 0.0Community Rank: 1.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
GBX 141.50
+1.50 (+1.07 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive COG News and Ratings via Email

Sign-up to receive the latest news and ratings for COG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Cambridge Cognition (LON:COG) Frequently Asked Questions

What stocks does MarketBeat like better than Cambridge Cognition?

Wall Street analysts have given Cambridge Cognition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cambridge Cognition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Cambridge Cognition's earnings last quarter?

Cambridge Cognition Holdings Plc (LON:COG) issued its quarterly earnings data on Tuesday, September, 22nd. The company reported ($1.50) earnings per share for the quarter.
View Cambridge Cognition's earnings history

How has Cambridge Cognition's stock been impacted by Coronavirus (COVID-19)?

Cambridge Cognition's stock was trading at GBX 20.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, COG stock has increased by 600.5% and is now trading at GBX 141.50.
View which stocks have been most impacted by COVID-19

Who are Cambridge Cognition's key executives?

Cambridge Cognition's management team includes the following people:
  • Dr. Matthew Stork, CEO & Director
  • Mr. Nicholas John Cordeaux Walters, Exec. Director (Age 63, Pay $48k)
  • Mr. John Hammond, Co-Founder
  • Mr. Michael Holton, Chief Financial Officer
  • Mr. Nick Taptiklis, Head of Technology Strategy
  • Dr. Jenny H. Barnett, Chief Scientific Officer
  • Mr. Simon Merritt, Marketing and Communications Director
  • Dr. Lisa Elizabeth Nolan, VP Bus. Devel. (Age 59)
  • Ms. Nicky Ackerley, Global HR Director
  • Prof. Trevor Robbins, Sr. Consultant

Who are some of Cambridge Cognition's key competitors?

What other stocks do shareholders of Cambridge Cognition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cambridge Cognition investors own include Interserve (IRV), Alio Gold Inc. (ALO.TO) (ALO), Concepta PLC (CPT.L) (CPT), European Metals (EMH), IntelGenx Technologies (IGXT), Oxford Biomedica (OXB), Syneos Health (SYNH), The Travelers Companies (TRV), Amryt Pharma (AMYT) and AltynGold (ALTN).

What is Cambridge Cognition's stock symbol?

Cambridge Cognition trades on the London Stock Exchange (LON) under the ticker symbol "COG."

How do I buy shares of Cambridge Cognition?

Shares of COG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Cambridge Cognition's stock price today?

One share of COG stock can currently be purchased for approximately GBX 141.50.

How much money does Cambridge Cognition make?

Cambridge Cognition has a market capitalization of £44.11 million and generates £6.74 million in revenue each year.

How many employees does Cambridge Cognition have?

Cambridge Cognition employs 71 workers across the globe.

What is Cambridge Cognition's official website?

The official website for Cambridge Cognition is www.cambridgecognition.com.

Where are Cambridge Cognition's headquarters?

Cambridge Cognition is headquartered at Tunbridge Court Tunbridge Lane, Bottisham, CAMBRIDGE, CB25 9TU, United Kingdom.

How can I contact Cambridge Cognition?

Cambridge Cognition's mailing address is Tunbridge Court Tunbridge Lane, Bottisham, CAMBRIDGE, CB25 9TU, United Kingdom. The company can be reached via phone at 44 1223 810 700.

This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.